Jerzy Gumulka
Director/Board Member at CNS PHARMACEUTICALS, INC.
Net worth: 15 568 $ as of 31/03/2024
Profile
Jerzy Gumulka is an Independent Director at CNS Pharmaceuticals, Inc. since 2017.
He was a Director at Moleculin LLC from 2010 to 2016.
Prior to that, he was a Technical Director at Kraton Polymers do Brasil SA from 2001 to 2015 and a Technology Manager at Kraton Polymers U.S.
LLC from 2001 to 2016.
Dr. Gumulka holds a doctorate degree from the University of Warsaw.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
08/04/2024 | 43,006 ( 0.51% ) | 15 568 $ | 31/03/2024 |
Jerzy Gumulka active positions
Companies | Position | Start |
---|---|---|
CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2017 |
Former positions of Jerzy Gumulka
Companies | Position | End |
---|---|---|
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01/06/2016 |
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Director/Board Member | 01/01/2016 |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Training of Jerzy Gumulka
University of Warsaw | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Health Technology |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Producer Manufacturing |
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Process Industries |
CNS Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Jerzy Gumulka